Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study

被引:0
作者
Qian Peng
Xiang Cao
Jing Wang
Lin Wang
Jun Xu
Xiaowei Ji
Suying Liu
Jin Zhu
Xi Dong
机构
[1] Zhongshan hospital,Reproductive medicine centre
[2] Fudan University,Department of Obstetrics and Gynecology
[3] Shanghai Obstetrics and Gynecology Hospital,undefined
[4] Fudan University,undefined
来源
Reproductive Biology and Endocrinology | / 17卷
关键词
Progestin-primed ovarian stimulation; Mild stimulation; Advanced maternal age; Embryo quality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 216 条
[1]  
Drakopoulos P(2016)Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod 31 370-376
[2]  
Blockeel C(2015)Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization Fertil Steril 103 931-938
[3]  
Stoop D(2017)Mild stimulation for in vitro fertilization Fertil Steril 108 558-567
[4]  
Camus M(2017)A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial Hum Reprod 32 112-118
[5]  
de Vos M(2015)Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization Fertil Steril 104 62-70
[6]  
Tournaye H(2015)Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization Medicine (Baltimore) 94 e909-102
[7]  
Polyzos NP(2019)Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: a retrospective study J Gynecol Obstet Hum Reprod 48 99-1055
[8]  
Baker VL(2017)Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders Reprod Biol Endocrinol 15 71-237
[9]  
Brown MB(2016)Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial Medicine (Baltimore) 95 1048-1449
[10]  
Luke B(2017)The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial BJOG 124 229-1624